Access this stock data via API
Subscribe
Immunovia AB
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 101K 90K 139K 455K
Cost of revenue 36K 0
Gross profit 65K 455K
Operating expense
Research & development
Selling general and admin
Other operating expenses 14.7M 13.0M 9.1M 21.8M
Operating income -25.1M -20.1M -18.9M -30.1M
Non operating interest income
Income 11K 11K 26K 33.2M
Expense 4.7M 21.0M 38.9M 17K
Other income expense
Pretax income -29.7M -41.1M -57.8M 3.1M
Tax provision 0 0 0
Net income -29.7M -41.1M -57.8M 3.1M
Basic EPS -0.1 -0.1 -0.2 0.0
Diluted EPS -0.1 -0.1 -0.2 0.0
Basic average shares 383.0M 383.0M 310.5M 218.3M
Diluted average shares 383.0M 383.0M 310.5M 218.3M
EBITDA -24.6M -19.7M -18.0M 4.4M
Net income from continuing op. -25.1M -20.1M -18.9M -30.1M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 4 hours 4 minutes

04:55
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).